Comprehensive Transcriptional Analysis of Early-Stage Urothelial CarcinomaJakob Hedegaard, Lars Dyrskjøt, Mattias Aine et al.|Cancer Cell|2016Cited by 654
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia V. Lindskrog, Lars Dyrskjøt, Frederik Prip et al.|Nature Communications|2021Cited by 381
Prognostic Impact of a 12-gene Progression Score in Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Validation StudyLars Dyrskjøt, Torben F. Ørntoft, Thomas Reinert et al.|European Urology|2017Cited by 100
Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk GroupsKim E.M. van Kessel, Ellen C. Zwarthoff, Kirstin A. van der Keur et al.|Clinical Cancer Research|2018Cited by 92
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†Bas W.G. van Rhijn, Tahlita C.M. Zuiverloon, Laura S. Mertens et al.|European Urology|2020Cited by 89